Economy/AP

[Print]  [Email]        

Generex Biotechnology has additional 180 calendar days to regain Nasdaq listing compliance


Associated Press
11/10/09 4:00 PM EST

WORCESTER, MASS. — Generex Biotechnology Corp. said Tuesday it has an additional 180 calendar days to regain compliance with the NASDAQ Stock Market's listing maintenance requirements.

The company will regain compliance if the bid price of its common stock closes at $1 per share or more for a minimum of 10 consecutive business days before May 5, 2010.

Shares fell 1 cent to 54 cents in afternoon trading. The stock has traded between 8 cents and $1.14 over the past 52 weeks.



To view this site, you need to have Flash Player 8.0 or later installed. Click here to get the latest Flash player.


Most Popular Headlines





 


 



 

Reader Comments

All comments on this page are subject to our Terms of Use and do not necessarily reflect the views of the Examiner or its staff. Comment box is limited to 250 words.

Post a comment


Email:
(This will not be displayed or shared. Privacy Policy)

Your Name:

Comment:




Local

Another snowball fight planned for Dupont Circle

The Official Dupont Circle Snowball Fight facebook fanpage has over 6,000 fans now, and it looks as if snowed in DC'ers will return for another battle. Full story

Politics

GOP winning war over Miranda rights for terrorists

Even as the administration defends its decision to grant accused Detroit bomber Umar Farouk Abdulmutallab the right to remain silent, the president himself is hinting that things might be done differently in the future. Full story

Local

D.C. region braces for up to 20 more inches of snow

The National Weather Service has the entire D.C. metro area, from Prince William County north, under a winter storm warning for 10 to 20 inches of snow. Forecasters have had their eyes on this storm for days, but the projected snow totals were bumped up late Monday. Full story